NeuroMetrix has announced the launch of Quell, which is now available on the Companyâs product website at QuellRelief.com. Quell is an easy-to-use, over-the-counter chronic pain relief device. This first-of-its-kind wearable device utilizes NeuroMetrix’s patented, non-invasive nerve stimulation technology to provide 100 percent drug-free chronic pain relief.
It is designed for people with painful diabetic neuropathy, sciatica, osteoarthritis and fibromyalgia, among other conditions.
“There are an estimated 100 million people living with chronic pain in the U.S., and many are not experiencing adequate relief with currently available treatment options or want to avoid opioid medications that may incur added risk and side effects,” says Dr Paul Christo, Pain Specialist and Host of the nationally syndicated radio show Aches and Gains.
“I am excited by the possibilities non-medication options like wearable transcutaneous electrical nerve stimulation (TENS) devices can provide people living with chronic pain, particularly because they do not carry a risk of opioid dependence and side effects, and do not require invasive surgeries,” Christo added.
Quell received FDA clearance in July 2014 for chronic pain relief and use during night time sleep without a prescription. The FDA submission for Quell was based on its predecessor, Sensus, which has provided over 2.5 million hours of therapy to chronic pain sufferers throughout the United States.